Pages that link to "Q85317247"

The following pages link to Differential Expression of Cancer Stem Cell Markers ALDH1 and CD133 in Various Lung Cancer Subtypes (Q85317247):

Displaying 23 items.

• Melanoma Cancer Stem Cells: Markers and Functions (Q26765435) (← links)
• Cancer stem cells in small cell lung cancer (Q26767026) (← links)
• Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer. (Q33709790) (← links)
• Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells (Q36998251) (← links)
• MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype (Q37706921) (← links)
• Lung cancer and β-glucans: review of potential therapeutic applications (Q39183310) (← links)
• Activation of D2 Dopamine Receptors in CD133 ve Cancer Stem Cells in Non-small Cell Lung Carcinoma Inhibits Proliferation, Clonogenic Ability, and Invasiveness of These Cells (Q40440133) (← links)
• Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma (Q47627396) (← links)
• miR-367 stimulates Wnt cascade activation through degrading FBXW7 in NSCLC stem cells. (Q47757966) (← links)
• Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma. (Q48182109) (← links)
• Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma. (Q50482018) (← links)
• Silencing of Btbd7 Inhibited Epithelial-Mesenchymal Transition and Chemoresistance in CD133 Lung Carcinoma A549 Cells (Q51256517) (← links)
• Reduced expression of CXCR4, a novel renal cancer stem cell marker, is associated with high-grade renal cell carcinoma (Q51496684) (← links)
• Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas. (Q53578113) (← links)
• Differential role of Wnt signaling and base excision repair pathways in gastric adenocarcinoma aggressiveness. (Q53652240) (← links)
• Cytokeratin 19 (KRT19) has a Role in the Reprogramming of Cancer Stem Cell-Like Cells to Less Aggressive and More Drug-Sensitive Cells. (Q55143746) (← links)
• Immunophenotype evaluation of Non-Hodgkin's lymphomas. (Q55385039) (← links)
• Molecular epidemiology of lung cancer in Iran: implications for drug development and cancer prevention (Q56891493) (← links)
• Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients (Q57174616) (← links)
• Stabilization of miRNAs in esophageal cancer contributes to radioresistance and limits efficacy of therapy (Q57468054) (← links)
• Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas (Q58799507) (← links)
• Cancer stem cell impact on clinical oncology (Q60934336) (← links)
• Increased expression of DCLK1, a novel putative CSC maker, is associated with tumor aggressiveness and worse disease-specific survival in patients with bladder carcinomas (Q91560750) (← links)